ISPOR ANNOUNCES 2016-2017 BOARD OF DIRECTORS

Published Jul 5, 2016
Princeton, NJ—July 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the election of the Society’s 2016-2017 Board of Directors that assumed office on July 1, 2016. ISPOR’s Board of Directors are elected by its global membership. Lou Garrison, PhD assumes the role of President for 2016-17 after most recently serving as the Society’s President-Elect. Dr. Garrison is Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington in Seattle, WA, USA. Shelby D. Reed, RPh, PhD was elected to serve as President-Elect for the Society for 2016-17. Dr. Reed is Professor, Duke University in Durham, NC, USA. The following were elected as ISPOR Board Members for 2016-18: - Joanna Lis, MSc, MBA, PhD, Director of Market Access, Sanofi-Aventis (Warsaw, Poland) - Gordon Liu, PhD, PKU Yangtze River Scholar Professor of Economics, Peking University National School of Development, Director, PKU China Center for Health Economic Research (Beijing, China) - Rosanna Tarricone, MSc, PhD, Associate Professor, Bocconi University (Milan, Italy) - John Watkins, MPH, PharmD, Formulary Manager, Premera Blue Cross (Mountlake Terrace, WA, USA) Returning Board members include: Past President: - Daniel C. Malone, RPh, PhD, Professor of Pharmacy, College of Pharmacy and Associate Professor in Mel and Enid Zuckerman College, University of Arizona (Tucson, AZ, USA)  Treasurer: - Zeba M. Khan, RPh, PhD, Vice President, Celgene Corporation (Summit, NJ, USA) CEO and Executive Director: - Nancy S. Berg, CEO and Executive Director, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (Lawrenceville, NJ, USA) Directors: - Nancy Devlin, PhD, Director of Research, Office of Health Economics (London, UK) - Manuel Espinoza, MD, MSc, PhD, Professor, Department of Public Health and Chief, HTA Unit, Catholic University of Chile (Santiago, Chile) and Honorary Visiting Fellow, Centre for Health Economics University of York (York, UK) - Dana Goldman, PhD, Leonard D. Schaeffer Director's Chair and Director, Schaeffer Center for Health Policy and Economics, University of Southern California (Los Angeles, CA, USA)

###

Related Stories

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

Oct 14, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×